Statements (23)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:biotechnology
|
gptkbp:CEO |
gptkb:Aoife_Brennan
|
gptkbp:collaboratedWith |
gptkb:Ginkgo_Bioworks
gptkb:Roche |
gptkbp:country |
gptkb:United_States
|
gptkbp:focusesOn |
synthetic biology
engineered bacteria therapeutics |
gptkbp:foundedYear |
2014
|
gptkbp:founder |
gptkb:James_Collins
gptkb:Timothy_Lu |
gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
https://www.w3.org/2000/01/rdf-schema#label |
Synlogic
|
gptkbp:industry |
gptkb:biotechnology
|
gptkbp:notableProduct |
gptkb:Synthetic_Biotic_medicines
|
gptkbp:publiclyTraded |
yes
|
gptkbp:researchArea |
immunology
oncology metabolic diseases |
gptkbp:stockExchange |
gptkb:NASDAQ
|
gptkbp:stockSymbol |
gptkb:SYBX
|
gptkbp:website |
https://www.synlogictx.com/
|
gptkbp:bfsParent |
gptkb:Ginkgo_Bioworks
|
gptkbp:bfsLayer |
5
|